Figure 2
From: Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
PLS-DA of the MR spectra from biopsies excised post-treatment. (A) A score plot separating survivors and non-survivors, (B) Representative spectra showing the metabolic differences of the tumors of survivors and non-survivors. (C) The loadings of the PLS-DA model with variables colored according to the VIP scores. β-Glc, β-glucose; Lac, lactate, Gly, glycine; Cr, creatine; Ala, alanine.